Turnstone Biologics Stock (NASDAQ: TSBX) stock price, news, charts, stock research, profile.
Open | $2.49 |
Close | $2.55 |
Volume / Avg. | 22.03K / 136.04K |
Day Range | 2.48 - 2.59 |
52 Wk Range | 1.63 - 13.20 |
Market Cap | $57.36M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 50 |
Short Interest | 1.35% |
Days to Cover | 1.46 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Turnstone Biologics (NASDAQ:TSBX) through any online brokerage.
Other companies in Turnstone Biologics’s space includes: HOOKIPA Pharma (NASDAQ:HOOK), Fortress Biotech (NASDAQ:FBIO), Estrella Immunopharma (NASDAQ:ESLA), Intensity Therapeutics (NASDAQ:INTS) and Barinthus Biotherapeutics (NASDAQ:BRNS).
There is no analysis for Turnstone Biologics.
Turnstone Biologics has a consensus price target of $19.00.
The stock price for Turnstone Biologics (NASDAQ: TSBX) is $2.48 last updated July 25, 2024 at 8:37 AM EDT.
There are no upcoming dividends for Turnstone Biologics.
Turnstone Biologics’s Q2 earnings are confirmed for Friday, August 30, 2024.
There is no upcoming split for Turnstone Biologics.
Turnstone Biologics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.